Explore STIWatch.org and Get the Latest Resources to Navigate the IUSTI & STI Prevention Meetings
View this email in your browser ([link removed])
[link removed] September 16, 2024
** Explore STIWatch.org and get the latest resources to navigate the IUSTI & STI Prevention meetings!
------------------------------------------------------------
Dear Advocate,
AVAC is delighted to share its all-new STIWatch.org ([link removed]) website just as advocates, clinicians, researchers and partners convene in Atlanta, GA for the Centers for Disease Control and Prevention STI Prevention Conference ([link removed]) , and in Sydney, Australia for the 25th International Union Against Sexually Transmitted Infections (IUSTI) ([link removed]) World Congress.
Rates of sexually transmitted infections (STIs) continue to rise globally with too little public health intervention and investment. While many STIs are curable, they often go undiagnosed and untreated because they tend to cause few or no initial symptoms. Available diagnostics are often too costly to use for routine screening and testing in many low to middle-income countries (LMICs), and few vaccines exist to address the most common STIs.
Discover STIWatch.org!
[link removed]
STIWatch.org is an updated platform designed to enhance understanding and advocacy for STI vaccine and diagnostics research, development, and rollout. It offers comprehensive information on common STIs ([link removed]) , a clinical trials dashboard ([link removed]) , advocacy priorities, and a range of resources and tools ([link removed]) to support STI prevention and treatment efforts.
Scroll down for more STI prevention resources advocates need to navigate these two conferences.
Resources
Follow the STI Prevention Conference events in real time in Atlanta on Twitter at #STIConf24 and on AVAC's feed at @HIVpxresearch
[link removed]
**
------------------------------------------------------------
STI Clinical Trial Das ([link removed]) hboard ([link removed]) : shares the latest STI research on diagnostics and vaccines
**
------------------------------------------------------------
STIs: A Review of the 2022 Vaccine and Diagnostic R&D Pipeline and Investments ([link removed]) : provides an annual analysis of global funding trends for STI prevention research
[link removed]
Advocates’ Guide to Doxycycline to Prevent Bacterial STIs (DoxyPEP) ([link removed]) : explores and addresses the explore and address the critical questions around who will benefit most from DoxyPEP and how to implement this strategy broadly to ensure equitable access.
STIWatch.org is an initiative of AVAC with funding and support from the World Health Organization, the Bill & Melinda Gates Foundation and the National Institutes of Allergy and Infectious Diseases.
Contact
[email protected] for more information. To receive email updates from AVAC, signup here ([link removed]) .
Best,
AVAC
Follow us @hivpxresearch ([link removed])
[link removed] [link removed] [link removed]
Share this issue ([link removed]) [link removed]
AVAC Global Advocacy for HIV Prevention
+1 212 796 6423
[email protected] (mailto:
[email protected]) www.avac.org ([link removed])
You're receiving this because you signed up for our newsletter. Not interested any longer?
Manage email preferences ([link removed]) | Unsubscribe ([link removed])